AARTIPHARM Quarterly Results, Profit & Loss, Balance Sheet (AARTIPHARM)

AARTIPHARM quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • AARTIPHARM Financials
  • AARTIPHARM Shareholding Pattern
  • AARTIPHARM Earnings Documents
  • AARTIPHARM Announcements
  • AARTIPHARM Corporate Actions
  • AARTIPHARM Bulk, Block & Insider Deals
  • AARTIPHARM Delivery Data
  • AARTIPHARM Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Aarti Pharmalabs Ltd (AARTIPHARM) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Aarti Pharmalabs Ltd reported sales of ₹536 Cr, operating profit of ₹136 Cr (OPM 25%) and net profit of ₹76 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.

AARTIPHARM quarterly results (₹ Cr)
MetricSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales458538564386418432583536
Expenses364409418293344330470400
Operating Profit941291469374102113136
OPM20%24%26%24%18%24%19%25%
Other Income45-2202148
Interest6107711131713
Depreciation2123232325292830
Profit before tax7210111565396382101
Tax24%26%23%24%28%24%25%25%
Net Profit5574885028486176
EPS in Rs6.038.169.755.463.085.296.748.4
AARTIPHARM profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,2001,9451,8532,1151,8191,969
Expenses9931,6031,4671,6491,4501,543
Operating Profit207342386466369426
OPM17%18%21%22%20%22%
Other Income32581523
Interest122117274753
Depreciation42637387104112
Profit before tax155261300361233284
Tax21%26%28%24%25%-
Net Profit122193217272175213
EPS in Rs-21.3523.9330.0519.2723.51
Dividend Payout0%9%13%17%18%-
AARTIPHARM balance sheet (₹ Cr)
MetricMar 2023Mar 2024Mar 2025Sep 2025Mar 2026
Equity Capital4545454545
Reserves1,5131,7121,9452,0012,079
Borrowings215285413659754
Other Liabilities470540499561603
Total Liabilities2,2442,5822,9023,2663,482
Fixed Assets9261,0331,1371,5151,437
CWIP102137374160393
Investments8710777187194
Other Assets1,1301,3051,3151,4031,457
Total Assets2,2442,5822,9023,2663,482
AARTIPHARM cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-44250216330262
Cash from Investing Activity-139-158-215-412-431
Cash from Financing Activity260-1631065171
Net Cash Flow78-7112-172
Free Cash Flow-18513018-114-186
CFO/OP-11%91%71%85%84%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit-1191718584
AARTIPHARM ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1158410299117
Inventory Days272188230199280
Days Payable12310613594146
Cash Conversion Cycle264166197204251
Working Capital Days1119411010590
ROCE19%16%17%17%11%
  • AARTIPHARM Shareholding Pattern
  • AARTIPHARM Earnings Concalls
  • AARTIPHARM Growth Catalysts
  • AARTIPHARM Corporate Actions
  • AARTIPHARM Announcements
  • AARTIPHARM Results & Documents
  • AARTIPHARM Bulk & Block Deals
  • AARTIPHARM Delivery Data